Disc Medicine, Inc.
IRON
Rangering i aksjer
#4958
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Aksjekurs
$75.39
Sist synkronisert: 2026-10-22
Markedsverdi
$2.89B
Endring (1 dag)
-0.80%
Endring (1 år)
-9.92%
Land
US
Handel Disc Medicine, Inc. (IRON)
Kategori
Healthcare
P/S-forhold for Disc Medicine, Inc. (IRON)
P/S-forhold per October 2026 TTM: 0.00
Ifølge Disc Medicine, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0.00. Ved slutten av 2024 hadde selskapet et P/S-forhold på 0.00.
P/S-historikk for Disc Medicine, Inc. fra 2020 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 10.72 | - |
US
|
|
| 41.70 | - |
US
|
|
| 4.19 | - |
AU
|
|
| 5.80 | - |
BE
|
|
| 10.44 | - |
NL
|
